KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Comscore (SCOR) Research & Development (2016 - 2025)

Comscore (SCOR) has disclosed Research & Development for 16 consecutive years, with $7.1 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 18.33% to $7.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.2 million through Dec 2025, down 8.75% year-over-year, with the annual reading at $30.2 million for FY2025, 8.75% down from the prior year.
  • Research & Development for Q4 2025 was $7.1 million at Comscore, down from $7.2 million in the prior quarter.
  • The five-year high for Research & Development was $10.4 million in Q1 2021, with the low at $7.1 million in Q4 2025.
  • Average Research & Development over 5 years is $8.7 million, with a median of $8.8 million recorded in 2022.
  • The sharpest move saw Research & Development grew 9.42% in 2024, then dropped 18.33% in 2025.
  • Over 5 years, Research & Development stood at $9.6 million in 2021, then fell by 8.24% to $8.8 million in 2022, then dropped by 10.09% to $7.9 million in 2023, then rose by 9.42% to $8.7 million in 2024, then decreased by 18.33% to $7.1 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $7.1 million, $7.2 million, and $7.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.